期刊文献+

动态对比增强磁共振成像定量参数与半定量参数评估晚期肺癌患者放化疗敏感性的价值分析 被引量:3

Effects of quantitative parameters and semi-quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging in evaluating chemoradiotherapy sensitivity of patients with advanced lung cancer
下载PDF
导出
摘要 目的探讨动态对比增强磁共振成像(DCE-MRI)定量参数与半定量参数评估晚期肺癌患者放化疗敏感性的价值。方法36例局部晚期肺癌患者均采用同步放化疗治疗。所有病例均在同步放化疗前后进行常规磁共振平扫及DCE-MRI扫描,计算DCE-MRI半定量参数与定量参数。根据肿瘤退缩及病理学检查将患者分为敏感组(21例)与低敏感组(15例),比较两组各项参数差异。采用受试者工作特征(ROC)曲线分析定量参数与半定量参数评估晚期肺癌患者放化疗敏感性的价值。结果敏感组患者达峰时间(TIP)短于低敏感组,最大信号增强比率(SERmax)、正性增强积分(PEI)均高于低敏感组,差异均有统计学意义(P﹤0.05)。敏感组患者容量转移常数(Ktrans)、速率常数(Kep)均高于低敏感组,血管外细胞外间隙容积比(Ve)低于低敏感组,差异均有统计学意义(P﹤0.05)。半定量参数中TIP、SERmax、PEI的曲线下面积分别为0.586、0.482、0.599。TIP最佳诊断阈值是41.7 s,此时诊断灵敏度为78.3%,特异度为62.4%;PEI最佳诊断阈值是116.5,此时诊断灵敏度为66.4%,特异度为63.7%。定量参数中Ktrans、Kep、Ve的曲线下面积分别为0.735、0.688、0.711,所有曲线下面积均﹥0.6。Ktrans最佳诊断阈值是0.37 min-1,此时诊断灵敏度为81.6%,特异度为72.5%;Kep最佳诊断阈值是1.54 min-1,此时诊断灵敏度为65.2%,特异度为83.3%;Ve最佳诊断阈值是0.18,此时诊断灵敏度为85.4%,特异度为74.5%。结论DCE-MRI的半定量、定量参数均能有效评价晚期肺癌肿瘤消退情况,尤其是定量参数在评估放化疗敏感性方面较强。 Objective To explore the quantitative parameters and semi-quantitative parameters of dynamic contrast enhanced magnetic resonance imaging(DCE-MRI)in evaluating chemoradiotherapy sensitivity of patients with advanced lung cancer.Method A retrospective study was used to select 36 patients with locally advanced lung cancer confirmed by pathology as study subjects,and all patients were treated with concurrent chemoradiotherapy.All cases underwent rou-tine MRI plain scan and DCE-MRI scan before and after concurrent radiotherapy and chemotherapy,and the semi quanti-tative and quantitative parameters of DCE-MRI were calculated.Patients were divided into sensitivity group(n=21)and low-sensitivity group(n=15)according to the tumor regression and pathological examination,and the parameters were compared between the two groups.The receiver operating characteristic(ROC)curve was used to analyze the value of quantitative and semi quantitative parameters in evaluating the chemoradiotherapy sensitivity of patients with advanced lung cancer.Result The time to peak(TIP)of the sensitivity group was significantly shorter than that of low-sensitivity group,and the maximum ratio of signal enhancement(SERmax)and positive enhancement integral(PEI)were significantly higher than those of the low-sensitivity group(P<0.05).The volume transfer constant(Ktrans)and rate constant(Kep)of the sensitivity group were significantly higher than those of the low-sensitivity group,and the extracellular space volume ra-tio(Ve)value was significantly lower than that of low-sensitivity group(P<0.05).In the semi quantitative parameters,the areas under the curve of TIP,SERmax and PEI were 0.586,0.482 and 0.599 respectively.The best diagnostic threshold of tip was 41.7 s.At this time,the diagnostic sensitivity was 78.3%and the specificity was 62.4%.The optimal diagnostic threshold of PEI was 116.5.At this time,the diagnostic sensitivity was 66.4%and the specificity was 63.7%.In the quan-titative parameters,the areas under the curves of Ktrans,Kep and Ve were 0.735,0.688 and 0.711 respectively,and the areas under all curves were>0.6.The best diagnostic threshold of Ktrans was 0.37 min-1.At this time,the diagnostic sensitivity was 81.6%and the specificity was 72.5%.The best diagnostic threshold of Kep was 1.54 min-1.At this time,the diagnostic sensitivity was 65.2%and the specificity was 83.3%;The best diagnostic threshold of Ve was 0.18.At this time,the diag-nostic sensitivity was 85.4%and the specificity was 74.5%.Conclusion Semi-quantitative and quantitative parameters of DCE-MRI can effectively evaluate the regression of advanced lung cancer tumors,especially the quantitative parame-ters are strong in assessing the chemoradiotherapy sensitivity.
作者 孙素芳 孟静 刘琳 SUN Sufang;MENG Jing;LIU Lin(Department of Medical Imaging,Luohe Central Hospital(the First Affiliated Hospital of Luohe Medical College),Luohe 462000,He’nan,China)
出处 《癌症进展》 2022年第1期52-55,73,共5页 Oncology Progress
关键词 动态对比增强磁共振成像 肺癌 定量参数 半定量参数 dynamic contrast-enhanced magnetic resonance imaging lung cancer quantitative parameters semi quantitative parameters
  • 相关文献

参考文献13

二级参考文献74

  • 1邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 2Martin Früh,Estelle Roll,Jean-Pierre Pignon,Lesley Seymour,Keyue Ding,Hélène Tribodet,Timothy Winton,Thierry Le Chevalier,Giorgio V. Scagliotti,Jean Yves Douillard,Stephen Spiro,Frances A. Shephe.Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer. Japanese Journal of Clinical Oncology . 2008
  • 3Vinai Gondi,Rebecca Paulus,Deborah W. Bruner,Christina A. Meyers,Elizabeth M. Gore,Aaron Wolfson,Maria Werner-Wasik,Alexander Y. Sun,Hak Choy,Benjamin Movsas.??Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214(J)International Journal of Radiation Oncology, Biology, Physics . 2013 (4)
  • 4Bree R. Eaton,Sungjin Kim,David M. Marcus,Roshan Prabhu,Zhengjia Chen,Suresh S. Ramalingam,Walter J. Curran,Kristin A. Higgins.??Effect of prophylactic cranial irradiation on survival in elderly patients with limited‐stage small cell lung cancer(J)Cancer . 2013 (21)
  • 5Chirag Desai,Anurag Mehta,Divya Mishra.??Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey(J)Lung India . 2014 (3)
  • 6Weber WA. Assessing tumor response to therapy[J]. J Nucl Med,2009,50 Suppl 1: S1-S10. D01:10.2967/jnumed.108.057174.
  • 7Ohno Y, Koyama H, Yoshikawa T, et al. Diffusion-weightedMRI versus l8F-FDG PET/CT: performance as predictors oftumor treatment response and patient survival in patients withnon-small cell lung cancer receiving chemoradiotherapy[J].AJR Am J Roentgenol, 2012, 198(1): 75-82. D01:10.2214/AJR.11.6525.
  • 8Reischauer C, Froehlich JM, Pless M, et al. Early treatmentresponse in non-small cell lung cancer patients usingdiffusion-weighted imaging and functional diffusion maps : afeasibility study[J]. PLoS One, 2014, 9(10): el08052. DOI:10.1371/journal.pone.0108052.
  • 9Yabuuchi H, Hatakenaka M, Takayama K, et al. Non-smallcell lung cancer: detection of early response to chemotherapyby using contrast-enhanced dynamic and diffusion-weightedMR imaging[J]. Radiology, 2011, 261(2): 598-604. DOI:10.1148/radiol.lll01503.
  • 10Afaq A, Akin 0. Imaging assessment of tumor response: past,present and future[J]. Future Oncol, 2011,7(5): 669-677. DOI:I0.2217/fon.ll.38.

共引文献159

同被引文献51

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部